[1]
T. Popov, S. Maslyankov, A. Arabadzhiev, M. Sokolov, and S. Kandilarova, “Serum levels of semaphorin 4C in breast cancer – assessment of prognostic value and potential for monitoring surgical treatment response”, AMB, vol. 51, no. 4, pp. 1–7, Nov. 2024, doi: 10.2478/AMB-2024-0070.